Skip to content
Saturday, April 25, 2026

IPO Edge

IPO News & Views

  • Home
  • Companies
  • News
  • News

Final results of Bioretec Ltd’s rights issue

  • ipoedge.com
  • April 24, 2026

TAMPERE, Finland, April 24, 2026 — Bioretec Ltd Company announcement 24 April 2026 at […]

  • News

Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock

  • ipoedge.com
  • April 24, 2026

NEW YORK, April 24, 2026 — Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”), a […]

  • News

Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules

  • ipoedge.com
  • April 24, 2026

CRANFORD, N.J., April 24, 2026 — Citius Pharmaceuticals Inc. (Nasdaq: CTXR) (“Citius Pharma” or […]

  • News

Target Hospitality Announces Closing of Secondary Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

  • ipoedge.com
  • April 23, 2026

THE WOODLANDS, Texas, April 23, 2026 — Target Hospitality Corp. (“Target Hospitality” or the […]

  • News

Aircastle Announces Pricing of $650 Million Aggregate Principal Amount of 5.000% Senior Notes Due 2031

  • ipoedge.com
  • April 23, 2026

STAMFORD, Conn., April 23, 2026 — Aircastle Limited (“Aircastle”) announced today that it and […]

  • News

Nektar Therapeutics Announces Closing of $373.8 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

  • ipoedge.com
  • April 23, 2026

SAN FRANCISCO, April 23, 2026 — Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company […]

  • News

Lakewood-Amedex Biotherapeutics Announces Direct Listing on Nasdaq; Shares Trading Under the Symbol “LABT”

  • ipoedge.com
  • April 23, 2026

SARASOTA, Fla., April 23, 2026 — Lakewood-Amedex Biotherapeutics Inc., (NASDAQ: LABT), a clinical-stage biotechnology […]

  • News

Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock

  • ipoedge.com
  • April 23, 2026

NEW YORK, April 23, 2026 — Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”), a […]

  • News

Danaher Announces Pricing of Euro-Denominated Senior Notes Offering

  • ipoedge.com
  • April 22, 2026

WASHINGTON, April 22, 2026 — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today that it […]

Posts navigation

Older posts

Recent Posts

  • Final results of Bioretec Ltd’s rights issue
  • Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock
  • Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules
  • Target Hospitality Announces Closing of Secondary Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
  • Aircastle Announces Pricing of $650 Million Aggregate Principal Amount of 5.000% Senior Notes Due 2031

Recent Comments

No comments to show.

Archives

  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023

Categories

  • Companies
  • News
  • Uncategorized
Copyright © 2026 IPO Edge Theme: Adore News By Adore Themes.